RNS Number : 7474C
Creightons PLC
31 March 2025
 

Creightons plc

("Creightons" or the "Company")

Admission to trading on AIM and first day of dealings

Creightons, the British based beauty and well-being brand owner and manufacturer, is pleased to announce the admission of its entire issued share capital*, being 70,035,383 ordinary shares of one penny each ("Ordinary Shares"), to trading on AIM, a market operated by the London Stock Exchange plc ("Admission").

Admission and dealings in the Ordinary Shares will commence at 8.00 a.m. today under the same TIDM and ISIN of CRL and GB0002341666, respectively. Cancellation of the Company's Ordinary Shares on the Equity Shares (Commercial Company) category of the Main Market will take place simultaneously.

Further information in relation to Admission can be found in the Company's Schedule One announcement published on 28 February 2025. An appendix to the Schedule One, as well as information required pursuant to AIM Rule 26, is available on the Company's website at https://creightonsplc.com/investors/shareholder-documents/#documents.

*Of the 70,035,383 Orindary Shares, 1,600,000 Ordinary Shares are held in treasury, therefore total voting rights of 68,435,383

For enquiries, please contact:

Creightons plc

+44 1733 281058

Paul Forster, Chairman


Philippa Clark, CEO




Zeus (Nominated Adviser and Broker)

+44 203 829 5000

David Foreman / Ed Beddows (Investment Banking)


Nick Searle (Sales)


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBXGDXRDDDGUI